z-logo
open-access-imgOpen Access
Primary Hyperaldosteronism: A Rare Cause of Malignant Hypertension with Thrombotic Microangiopathy in a Kidney Transplant Recipient
Author(s) -
Carolina Ormonde,
Sara Querido,
Nuno Rombo,
Rita Roque,
Belarmino Clemente,
André Weigert
Publication year - 2021
Publication title -
case reports in transplantation
Language(s) - English
Resource type - Journals
eISSN - 2090-6943
pISSN - 2090-6951
DOI - 10.1155/2021/9261371
Subject(s) - thrombotic microangiopathy , medicine , thrombotic thrombocytopenic purpura , microangiopathy , secondary hypertension , calcineurin , kidney disease , hyperaldosteronism , kidney , haemolysis , immunology , gastroenterology , pathology , disease , transplantation , endocrinology , diabetes mellitus , platelet , blood pressure , aldosterone
Thrombotic microangiopathy (TMA) is a rare disease that presents with haemolysis and organ damage. The kidney is one of the main affected organs, and TMA is associated with serious complications and increased mortality. In transplanted patients, TMA is even less common and has a variety of possible causes, including thrombotic thrombocytopenic purpura (TTP) and haemolytic-uremic syndrome (HUS), infections, drugs, autoimmune disease, tumours, and malignant hypertension. Transplant-related causes, such as antibody-mediated rejection, calcineurin inhibitors, and viral infections, need to be considered as well. The authors report a rare case of TMA in a kidney transplant recipient, whose investigation revealed malignant hypertension secondary to primary hyperaldosteronism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom